Clinical and Cardiac Safety of Long-term Levofloxacin in Children Treated for Multidrug-resistant Tuberculosis

Safety concerns persist for long-term pediatric fluoroquinolone use. Seventy children (median age, 2.1 years) treated with levofloxacin 10–20 mg/kg once daily for multidrug-resistant tuberculosis (median observation time, 11.8 months) had few musculoskeletal events, no levofloxacin-attributed seriou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Garcia-Prats, Anthony J, Draper, Heather R, Finlayson, Heather, Winckler, Jana, Burger, André, Fourie, Barend, Thee, Stephanie, Hesseling, Anneke C, Schaaf, H Simon
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6233673/
https://ncbi.nlm.nih.gov/pubmed/29788331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy416
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados